RECODE THERAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 09 May 2025)
What this means for you
Not registered yet, but its 08 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97354266
- Mark type
- Stylized text
- Filed
- 08 Apr 2022
- Published for opposition
- 28 Mar 2023
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Medicines for the modification of genes and treatment of diseases, for use in the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; cell and gene therapy biological preparations and pharmaceutical preparations with protein expression, all for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; drug carriers for medical use, namely, delivery agents in the form of non-viral lipid nanoparticles for delivering drugs to human organs that facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment and prevention of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer
- Class 009 — Scientific and electric apparatus: Downloadable electronic publications in the nature of articles, books, magazines, journals, and scientific texts in the fields of genetic medicine and drug delivery
- Class 041 — Education and entertainment services: Providing online non-downloadable articles, books, magazines, journals, and scientific texts in the fields of genetic medicine and drug delivery
- Class 042 — Scientific and technological services: Scientific and biotechnology research and analysis in the fields of cell and gene therapy and drug delivery; research and development of medicines and drug delivery platforms for the treatment of diseases; providing scientific research and medical research information in the fields of genetic medicine and drug delivery; medical and scientific research in the field of pharmaceuticals; pharmaceutical research and products development of pharmaceuticals for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer
- Class 044 — Medical, beauty and agricultural services: Providing medical information in the fields of genetic medicine and drug delivery
Owner
- ReCode Therapeutics, Inc., Menlo Park, CA, US
- ReCode Therapeutics, Inc., Menlo Park, CA, US
Prosecution history
- 31 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 09 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 May 2025 — SOU EXTENSION 4 GRANTED
- 08 May 2025 — SOU EXTENSION 4 FILED
- 08 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Nov 2024 — SOU EXTENSION 3 GRANTED
- 20 Nov 2024 — SOU EXTENSION 3 FILED
- 20 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 24 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 May 2024 — SOU EXTENSION 2 GRANTED
- 23 May 2024 — SOU EXTENSION 2 FILED
- 23 May 2024 — SOU TEAS EXTENSION RECEIVED
- 16 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Nov 2023 — SOU EXTENSION 1 GRANTED